What is the recommended treatment for Bell's palsy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bell's Palsy

Oral corticosteroids initiated within 72 hours of symptom onset are the only proven effective treatment for Bell's palsy, with prednisolone 50 mg daily for 10 days or prednisone 60 mg daily for 5 days followed by a 5-day taper. 1

Evidence for Corticosteroid Efficacy

The evidence supporting early corticosteroid therapy is robust and consistent:

  • 83% of patients achieve complete recovery at 3 months with prednisolone versus 63.6% with placebo (absolute benefit 19.4%; NNT = 6) 1
  • 94.4% achieve complete recovery at 9 months with prednisolone versus 81.6% with placebo (absolute benefit 12.8%; NNT = 8) 1
  • Treatment must be initiated within 72 hours of symptom onset; no evidence supports benefit when started later 1, 2

The American Academy of Otolaryngology-Head and Neck Surgery gives this a strong recommendation based on high-quality randomized controlled trials 1. This is echoed by Japanese guidelines 3, French guidelines 4, and recent systematic reviews 5.

Antiviral Therapy: Limited Role

Antiviral monotherapy should never be prescribed for Bell's palsy—it is completely ineffective. 1, 5

Combination therapy (steroids plus antivirals) may be considered but provides only modest incremental benefit:

  • One small trial showed 96.5% complete recovery with steroids + acyclovir versus 89.7% with steroids alone (absolute benefit 6.8%) 1
  • However, the large BELLS study (n=496) found no statistically significant advantage: 71.2% recovery with acyclovir versus 75.7% without (P=0.50) at 3 months 1
  • At 9 months, recovery was actually lower with acyclovir: 85.4% versus 90.8% without 1

If you choose to add antivirals, use valacyclovir 1000 mg three times daily for 7 days OR acyclovir 400 mg five times daily for 10 days, but only within 72 hours and only in combination with steroids. 1, 5 The AAO-HNS classifies this as an "option" rather than a recommendation, emphasizing the small benefit 1.

High-Dose Versus Standard-Dose Steroids

Recent evidence suggests high-dose corticosteroids (≥80 mg prednisone equivalent) may be superior to standard doses:

  • A 2023 meta-analysis found significantly decreased non-recovery at 6 months with high-dose versus standard-dose steroids (OR 0.17,95% CI 0.05-0.56, p=0.004) 6
  • However, all included studies had serious risk of bias, and adverse events (5.8%) were only reported in the high-dose group 6

Given the current evidence base and guideline recommendations, standard-dose therapy (prednisone 60 mg daily or prednisolone 50 mg daily) remains the appropriate choice for most patients. 1 High-dose regimens may be considered for severe cases but lack robust safety data 6.

Critical Timing Window

The 72-hour window is absolute. 1, 2

  • Clinical trials demonstrating steroid efficacy specifically enrolled patients within 72 hours 2
  • Treatment initiated at day 5 (as in your question) provides no proven benefit and exposes patients to medication risks without evidence of efficacy 2
  • If a patient presents beyond 72 hours, focus on eye protection and supportive care rather than initiating steroids 2

Essential Eye Protection (All Patients with Incomplete Eye Closure)

Eye protection is mandatory and takes priority when steroids cannot be given:

  • Lubricating ophthalmic drops every 1-2 hours while awake 1
  • Ophthalmic ointment at bedtime for sustained moisture 1
  • Eye taping or patching at night with proper technique to avoid corneal abrasion 1
  • Sunglasses outdoors to shield from wind and debris 1
  • Urgent ophthalmology referral for severe impairment or signs of corneal exposure 1

Failure to implement eye protection can result in permanent corneal damage, including exposure keratitis 1.

Special Populations

Pregnancy

Pregnant women should receive oral corticosteroids within 72 hours after individualized risk-benefit assessment. 1 The therapeutic benefit outweighs the risk of temporary hyperglycemia 1. Eye protection measures are essential and safe in pregnancy 1.

Diabetes

Diabetes is not a contraindication to corticosteroid therapy. 1 The therapeutic benefit outweighs the risk of temporary hyperglycemia 1. Implement aggressive glucose monitoring:

  • Check capillary blood glucose every 2-4 hours during the first few days 1
  • Administer steroids in the morning to align with natural cortisol rhythm 1
  • Proactively increase basal insulin and add/increase prandial insulin 1
  • For patients on oral agents, add NPH insulin concurrent with morning steroid dose 1

Children

Children have better prognosis with higher spontaneous recovery rates (up to 90%) than adults 2, 5. Evidence for steroid benefit in children is inconclusive 1. Consider oral corticosteroids on an individualized basis with substantial caregiver participation in shared decision-making. 1

Interventions NOT Recommended

Physical therapy has no proven benefit over spontaneous recovery and should not be used as primary treatment 1, 7. One recent case report suggested benefit from osteopathic manipulation and physical therapy 8, but this is low-quality evidence and the patient may have experienced spontaneous resolution.

Acupuncture cannot be recommended due to poor-quality trials and indeterminate benefit-harm ratio 1.

Surgical decompression is not advised except in rare, highly selected cases at specialized centers 1.

Mandatory Follow-Up and Referral Triggers

Refer to a facial nerve specialist if:

  • Incomplete facial recovery at 3 months after symptom onset 1
  • New or worsening neurologic findings at any time 1
  • Development of ocular symptoms at any point 1

Diagnostic Testing to Avoid

Do not obtain routine laboratory tests or imaging for typical Bell's palsy presentations 1, 7. This delays treatment beyond the critical 72-hour window without improving outcomes 1.

Reserve MRI (with and without contrast) for atypical presentations:

  • Recurrent paralysis on the same side 1
  • Isolated branch paralysis 1
  • Other cranial nerve involvement 1
  • Lack of recovery after 3 months 1
  • Progressive weakness beyond 3 weeks 1
  • Bilateral facial weakness 1

Electrodiagnostic testing is not recommended for incomplete facial paralysis and provides no actionable information 1. It may be offered for complete paralysis, ideally 3-14 days after onset 1.

Common Pitfalls

  • Prescribing antivirals alone is ineffective and delays appropriate steroid treatment 1
  • Using a standard methylprednisolone dose pack provides only ~105 mg prednisone-equivalent total versus the required ~540 mg, representing significant underdosing 1
  • Delaying treatment to await test results compromises the 72-hour window 1
  • Failing to implement eye protection can lead to permanent corneal damage 1
  • Not referring at 3 months delays access to reconstructive options 1

References

Guideline

Assessment and Management of Bell's Palsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Bell's Palsy at Day 5

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

French Society of ENT (SFORL) guidelines. Management of acute Bell's palsy.

European annals of otorhinolaryngology, head and neck diseases, 2020

Research

Bell Palsy: Rapid Evidence Review.

American family physician, 2023

Research

Comparing the Use of High-Dose to Standard-Dose Corticosteroids for the Treatment of Bell's Palsy in Adults-A Systematic Review and Meta-analysis.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2023

Guideline

Diagnostic Criteria and Exclusions for Bell's Palsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.